Business Description
Precipio Inc
NAICS : 334516
SIC : 3826
ISIN : US74019L6020
Total Employee Number:
71Description
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.75 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 3.74 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.68 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.9 | |||||
3-Year EPS without NRI Growth Rate | 60 | |||||
3-Year Book Growth Rate | -17 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.13 | |||||
9-Day RSI | 47.17 | |||||
14-Day RSI | 48.82 | |||||
3-1 Month Momentum % | -17.25 | |||||
6-1 Month Momentum % | -8.96 | |||||
12-1 Month Momentum % | 43.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 22.48 | |||||
Days Sales Outstanding | 23.72 | |||||
Days Payable | 28.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16 | |||||
Shareholder Yield % | -4.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.71 | |||||
Operating Margin % | -6.86 | |||||
Net Margin % | -3.57 | |||||
EBITDA Margin % | 3.61 | |||||
FCF Margin % | 2.15 | |||||
OCF Margin % | 3.07 | |||||
ROE % | -6.94 | |||||
ROA % | -4.62 | |||||
ROIC % | -10.46 | |||||
3-Year ROIIC % | 6984.94 | |||||
ROC (Joel Greenblatt) % | -22.28 | |||||
ROCE % | -5.42 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 30.4 | |||||
PS Ratio | 1.55 | |||||
PB Ratio | 3 | |||||
Price-to-Tangible-Book | 12.47 | |||||
Price-to-Free-Cash-Flow | 72.14 | |||||
Price-to-Operating-Cash-Flow | 50.76 | |||||
EV-to-EBIT | -50.56 | |||||
EV-to-EBITDA | 46.55 | |||||
EV-to-Revenue | 1.68 | |||||
EV-to-Forward-Revenue | 0.32 | |||||
EV-to-FCF | 78.25 | |||||
Price-to-GF-Value | 2.3 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | -1.98 | |||||
FCF Yield % | 1.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRPO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Precipio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 25.831 | ||
| EPS (TTM) ($) | -0.47 | ||
| Beta | 0.8944 | ||
| 3-Year Sharpe Ratio | 0.85 | ||
| 3-Year Sortino Ratio | 1.89 | ||
| Volatility % | 50.89 | ||
| 14-Day RSI | 48.82 | ||
| 14-Day ATR ($) | 1.950401 | ||
| 20-Day SMA ($) | 23.83784 | ||
| 12-1 Month Momentum % | 43.68 | ||
| 52-Week Range ($) | 13.02 - 33.63 | ||
| Shares Outstanding (Mil) | 1.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Precipio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Precipio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-17 17:00 | In 130 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 125 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 17:00 | In 35 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 34 days | ||
| Guidance call for 2026 | 2026-06-17 12:00 | 22.26 (+0.54%) | ||
| General meeting for 2026 | 2026-06-15 10:00 | 22.10 (+0.91%) | ||
| First quarter earnings conference call for 2026 | 2026-05-18 17:00 | 26.42 (-5.64%) | ||
| First quarter earnings results for 2026 | 2026-05-18 | 26.42 (-5.64%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-04-02 17:00 | 24.74 (-0.30%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-02 | 24.74 (-0.30%) |
Show
Entries
Precipio Inc Frequently Asked Questions
What is Precipio Inc(PRPO)'s stock price today?
The current price of PRPO is $24.31. The 52 week high of PRPO is $33.63 and 52 week low is $13.02.
When is next earnings date of Precipio Inc(PRPO)?
The next earnings date of Precipio Inc(PRPO) is 2026-08-14 Est..
Does Precipio Inc(PRPO) pay dividends? If so, how much?
Precipio Inc(PRPO) does not pay dividend.
Guru Commentaries on NAS:PRPO
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service | 2020-01-28 |
Articles on Precipio Inc
Headlines
See More- 1
Jun 11, 2026
Precipio to Present at the Planet MicroCap Las Vegas
Benzinga • 4:00pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers